At VJ BIO FARMA, we offer a diverse range of high-quality pharmaceutical products designed to meet the evolving needs of the global healthcare market. Our product portfolio includes bulk drugs, intermediates, formulations, and specialized molecules, with a focus on Oncology, Biosimilars, Peptides, Biologics, and more
Each product is carefully sourced and manufactured to adhere to the highest industry standards, ensuring safety, efficacy, and regulatory compliance. With our expertise and commitment to innovation, we continue to expand our portfolio, providing solutions that support pharmaceutical manufacturers in developing next-generation treatments.
Explore our comprehensive product list, which reflects our dedication to delivering cutting-edge, reliable solutions to the pharmaceutical industry.
| PRODUCT NAME | COA | DMF | GMP | WHO GMP | USFDA | CEP | WC | EUGMP |
|---|---|---|---|---|---|---|---|---|
| ANTI CANCER | ||||||||
| Abiraterone Acetate |
|
|
|
|
|
|
|
|
| Anastrazole |
|
|
|
|
|
In process
|
|
|
| Azacitadine |
|
|
|
|
|
|
|
|
| Bicalutamide |
|
|
|
|
|
In process
|
|
|
| Bortezomib |
|
|
|
|
|
In process
|
|
|
| Busulfan |
|
|
|
|
|
In process
|
|
|
| Capacitabine |
|
|
|
|
|
In process
|
|
|
| Carboplatin |
|
|
|
|
|
In process
|
|
|
| Cyclophosphamide |
|
|
|
|
|
In process
|
|
|
| Cytarabine |
|
|
|
|
|
In process
|
|
|
| Dasatinib |
|
|
|
|
|
In process
|
|
|
| Erlotinib |
|
|
|
|
|
In process
|
|
|
| Gefitinib |
|
|
|
|
|
In process
|
|
|
| Gemcitabine |
|
|
|
|
|
In process
|
|
|
| Imatinib |
|
|
|
|
|
|
|
|
| Irinotecan HCL |
|
|
|
|
|
|
|
|
| Letrozole |
|
|
|
|
|
In process
|
|
|
| Lapatinib |
|
|
|
|
|
|
|
|
| Mitomycin |
|
|
|
|
|
|
|
|
| Oxaliplatin |
|
|
|
|
|
|
|
|
| Sorafenib |
|
|
|
|
|
In process
|
|
|
| Temozolamide |
|
|
|
|
|
In process
|
|
|
| ANTI BIOTIC | ||||||||
| Mupirocin |
|
|
|
|
|
|
|
|
| Fusidic Acid |
|
|
|
|
|
|
|
|
| Rifampicin |
|
|
|
|
|
|
|
|
| Sirolimus |
|
|
|
|
|
|
|
|
| Teicoplanin |
|
|
|
|
|
|
|
|
| Vancomycin HCL |
|
|
|
|
|
|
|
|
| ANTI FUNGAL | ||||||||
| Caspofungin |
|
|
|
|
|
|
|
|
| Anidulafungin |
|
|
|
|
|
|
|
|
| Micafungin |
|
|
|
|
|
|
|
|
| Rezafungin |
|
|
|
|
|
|
|
|
| ANTI COAGULANT | ||||||||
| Heparin Sodium |
|
|
|
|
|
|
|
|
| Low Grade Glycosaminoglycans (LGG) |
|
|
|
|
|
|
|
|
| Enoxaparin Sodium |
|
|
|
|
|
|
|
|
| ANTI DIABETIC | ||||||||
| Dapagliflozin |
|
|
|
|
|
|
|
|
| Empagliflozin |
|
|
|
|
|
|
|
|
| IMMUNOSUPRASANT | ||||||||
| Cyclosporine |
|
|
|
|
|
|
|
|
| Everolimus |
|
|
|
|
|
|
|
|
| Mycophenolate Sodium |
|
|
|
|
|
|
|
|
| Mycophenolate Mofetil |
|
|
|
|
|
|
|
|
| Sirolimus |
|
|
|
|
|
|
|
|
| Tacrolimus |
|
|
|
|
|
|
|
|
| STERIOD HORMONE | ||||||||
| Dydrogesterone |
|
|
|
|
|
|
|
|
| Progesterone |
|
|
|
|
|
|
|
|
| HEPATOBILIARY | ||||||||
| Urodeoxycholic Acid (UDCA) |
|
|
|
|
|
|
|
|
| Chenodeoxycholic Acid (CDCA) |
|
|
|
|
|
|
|
|
| 7-ketolithocholic Acid (7KLCA) |
|
|
|
|
|
|
|
|
| OTHERS | ||||||||
| Erythropoietin |
|
|
|
|
|
|
|
|
| PRODUCT NAME | CAS NO. | SPECIFICATION | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTI CANCER | ||||||||
| Sunitinib | 557795-19-4 | IHS | ||||||
| Afatinib | 850140-72-6 | IHS | ||||||
| Axitinib | 319460-85-0 | IHS | ||||||
| Bendamustine HCl | 3543-75-7 | IP | ||||||
| Cisplatin | 15663-27-1 | USP/BP/IP | ||||||
| Carfilozomib | 868540-17-4 | IHS | ||||||
| Decitabine | 2353-33-5 | IHS | ||||||
| Methotrexate. | 59-05-2 | USP/BP/IP | ||||||
| Doxorubicin HCl | 25316-40-9 | USP/BP/IP | ||||||
| Enzalutamide | 915087-33-1 | IHS | ||||||
| Epirubicin HCl | 56390-09-1 | USP/BP | ||||||
| Etoposide | 33419-42-0 | USP/BP/IP | ||||||
| Exemestane | 107868-30-4 | USP/BP/IP | ||||||
| Lapatinib | 388082-78-8 | IP | ||||||
| Lenalidomide | 191732-72-6 | IHS | ||||||
| Pazopanib HCl | 635702-64-6 | IHS | ||||||
| Tamoxifen Citrate | 54965-24-1 | USP/BP/IP | ||||||
| 5-Fluorouracil | 17902-23-7 | IP | ||||||
| Paclitaxel | 33069-62-4 | USP | ||||||
| Pazopanib HCl | 635702-64-6 | IHS | ||||||
| Pemetrexed Disodium Heptahydrate | 357166-29-1 | USP/BP/IP | ||||||
| PRODUCT NAME | COA | DMF | GMP | EUGMP | USFDA | CEP | WC |
|---|---|---|---|---|---|---|---|
| Antibiotics | |||||||
| Ceftriaxone Sodium |
|
|
|
|
|
|
|
| Meropenem/Sterile |
|
|
|
|
|
|
|
| Meropenem With Sodium Carbonate |
|
|
|
|
|
|
|
| Aztreonam/Aztreonam Arginine |
|
|
|
|
|
|
|
| Fusidic Acid |
|
|
|
|
|
|
|
| Sodium Fusidate |
|
|
|
|
|
|
|
| Azithromycin |
|
|
|
|
|
|
|
| Azithromycin |
|
|
|
|
|
|
|
| Avibactam Sodium |
|
|
|
|
|
|
|
| Cefotaxime Sodium |
|
|
|
|
|
|
|
| Ceftizoxime Sodium |
|
|
|
|
|
|
|
| Vancomycin Hydrochloride |
|
|
|
|
|
|
|
| Bacitracin Zinc |
|
|
|
|
|
|
|
| Polymyxin B Sulfate |
|
|
|
|
|
|
|
| Polymyxin B Sulfate |
|
|
|
|
|
|
|
| Streptomycin Sulfate |
|
|
|
|
|
|
|
| Clindamycin Phosphate |
|
|
|
|
|
|
|
| Procaine Penicillin G |
|
|
|
|
|
|
|
| Sulfadoxine |
|
|
|
|
|
|
|
| Cardiovascular | |||||||
| Noradrenaline Bitartrate |
|
|
|
|
|
|
|
| Rocuronium Bromide |
|
|
|
|
|
|
|
| Heparin Sodium |
|
|
|
|
|
|
|
| Enoxaparin Sodium |
|
|
|
|
|
|
|
| Nadroparin Calcium |
|
|
|
|
|
|
|
| Low Grade Glycosaminoglycans |
|
|
|
|
|
|
|
| Steroids | |||||||
| Megestrol Acetate |
|
|
|
|
|
|
|
| Medroxyprogesterone Acetate |
|
|
|
|
|
|
|
| Dydrogesterone |
|
|
|
|
|
|
|
| Abiraterone Acetate |
|
|
|
|
|
|
|
| Mifepristone |
|
|
|
|
|
|
|
| Deflazacort |
|
|
|
|
|
|
|
| Anticancer | |||||||
| DHEA |
|
|
|
|
|
|
|
| Paclitaxel |
|
|
|
|
|
|
|
| Docetaxel |
|
|
|
|
|
|
|
| Carboplatin |
|
|
|
|
|
|
|
| Cisplatin |
|
|
|
|
|
|
|
| Oxaliplatin |
|
|
|
|
|
|
|
| Fulvestrant |
|
|
|
|
|
|
|
| Flumazenil |
|
|
|
|
|
|
|
| Fludarabine Phosphate |
|
|
|
|
|
|
|
| Peptides | |||||||
| Terlipressin Acetate |
|
|
|
|
|
|
|
| Octreotide Acetate |
|
|
|
|
|
|
|
| Semaglutide |
|
|
|
|
|
|
|
| Liraglutide |
|
|
|
|
|
|
|
| Aprotinin |
|
|
|
|
|
|
|
| HCG |
|
|
|
|
|
|
|
| Urokinase |
|
|
|
|
|
|
|
| Ulinastatin |
|
|
|
|
|
|
|
| Hypoglycins | |||||||
| Empagliflozin |
|
|
|
|
|
|
|
| Dapagliflozin |
|
|
|
|
|
|
|
| Teneligliptin |
|
|
|
|
|
|
|
| Sitagliptin Phosphate Monohydrate |
|
|
|
|
|
|
|
| Vitamin D Group | |||||||
| Paricalcitol |
|
|
|
|
|
|
|
| Calcidiol/calcifediol |
|
|
|
|
|
|
|
| Calcitriol |
|
|
|
|
|
|
|
| Alfacalcidol |
|
|
|
|
|
|
|
| Vitamin D2/D3 |
|
|
|
|
|
|
|
| Immunosuppressor | |||||||
| Tacrolimus |
|
|
|
|
|
|
|
| Rapamycin |
|
|
|
|
|
|
|
| Everolimus |
|
|
|
|
|
|
|
| Pimecrolimus |
|
|
|
|
|
|
|
| Hepatobiliary Drugs | |||||||
| Urodeoxycholic Acid(UDCA) |
|
|
|
|
|
|
|
| Ornithine Aspartate;LOLA |
|
|
|
|
|
|
|
| Glutathione; GSH |
|
|
|
|
|
|
|
| L- Carnitine |
|
|
|
|
|
|
|
| Others | |||||||
| Diosmin |
|
|
|
|
|
|
|
| Rutin |
|
|
|
|
|
|
|
| Tranexamic Acid |
|
|
|
|
|
|
|
| Procaine Hydrochloride |
|
|
|
|
|
|
|
| Propofol |
|
|
|
|
|
|
|
| PRODUCT NAME | COA | DMF (Total) | BIOSIMILARITY REPORT | STABILITY REPORT | MOA | PFD |
|---|---|---|---|---|---|---|
| Pembrolizumab |
|
|
|
|
|
|
| Nivolumab |
|
|
|
|
|
|
| Trastuzumab |
|
|
|
|
|
|
| Tocilizumab |
|
|
|
|
|
|
| Denosumab |
|
|
|
|
|
|
| Dupilumab |
|
|
|
|
|
|
| Tezepelumab |
|
|
|
|
|
|
| Supaglutide |
|
|
|
|
|
|
| Alirocumab |
|
|
|
|
|
|
| Secukinumab |
|
|
|
|
|
|
| Faricimab |
|
|
|
|
|
|
| Romosozumab |
|
|
|
|
|
|
| Aflibercept |
|
|
|
|
|
|
| Cetuximab |
|
|
|
|
|
|
| Rituximab |
|
|
|
|
|
|
| Bevacizumab |
|
|
|
|
|
|
| Adalimumab |
|
|
|
|
|
|
| Atezolizumab |
|
|
|
|
|
|
| Dulaglutide |
|
|
|
|
|
|
| Eculizumab |
|
|
|
|
|
|
| Omalizumab |
|
|
|
|
|
|
| Pertuzumab |
|
|
|
|
|
|
| Daratumumab |
|
|
|
|
|
|
| Iceanemab |
|
|
|
|
|
|
| Ipilimumab |
|
|
|
|
|
|
| Aducanumab |
|
|
|
|
|
|
| Evolocumab |
|
|
|
|
|
|
| Infliximab |
|
|
|
|
|
|
| Ramucirumab |
|
|
|
|
|
|
| Ustekinumab |
|
|
|
|
|
|
| Vedolizumab |
|
|
|
|
|
|
| Natalizumab |
|
|
|
|
|
|
| Panitumumab |
|
|
|
|
|
|
| Mepolizumab |
|
|
|
|
|
|
| Alemtuzumab |
|
|
|
|
|
|
| Dupliumab |
|
|
|
|
|
|
| Emicizumab |
|
|
|
|
|
|
| Ocrelizumab |
|
|
|
|
|
|
| Risankizumab |
|
|
|
|
|
|
| Casirivimab |
|
|
|
|
|
|
| Imdevimab |
|
|
|
|
|
|
| Benralizumab |
|
|
|
|
|
|
| Lecanemab |
|
|
|
|
|
|
| PRODUCT NAME | INTERMEDIATE NAME | CAS NO. |
|---|---|---|
|
Abrocitinib
|
Carbamic Acid,N-[cis-3-(methylamino)cyclobutyl]- Phenylmethyl Ester | 1353501-22-0 |
| Carbamic Acid,N-[cis-3-(methylamino)cyclobutyl]- Phenylmethyl Ester Hydrochloride | 2204290-99-1 | |
| 3-Oxocyclobutanecarboxylic Acid | 23761-23-1 | |
|
Abiraterone Acetate
|
DHEA | 53-43-0 |
| DHEA Iodine | 32138-69-5 | |
| Borane | 89878-14-8 | |
|
Acalabrutinib
|
[4-(2-pyridylcarbamoyl)phenyl]boronic Acid | 850568-25-1 |
| 3-Chloropyrazin-2-yl)MethanaMine Hydrochloride | 939412-86-9 | |
| N-(Pyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2- Dioxaborolan-2-yl)benzamide | 1383385-64-5 | |
| (S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin- 3-yl)pyrrolidine-1-carboxylate | 1420478-88-1 | |
| (3-chloropyrazin-2-yl)methanamine Hydrochloride | 867165-53-5 | |
|
Adagrasib
|
1-Bromo-8-chloronaphthalene | 20816-79-9 |
| Tert-Butyl 2,4-dichloro-5,6,7,8-tetrahydropyrido[3, 4-d]pyrimidine-7-carboxylate | 916420-27-4 | |
| 2-Propenoic Acid, 2-fluoro-, Sodium Salt | 74893-46-2 | |
| (R)-1-Boc-3-hydroxymethylpiperazine | 278788-66-2 | |
|
Apalutamide
|
Fragment A | 915087-25-1 |
| Fragment B | 951753-87-0 | |
| Fragment C | 573762-62-6 | |
|
Asciminib
|
(R)-3-Hydroxypyrrolidine | 2799-21-5 |
| 5-Bromo-6-chloronicotinic Acid | 29241-62-1 | |
| 1-(Tetrahydropyran-2-yl)-1H-pyrazole-5- Boronic Acid Pinacol Ester | 903550-26-5 | |
|
Atogepant
|
(S)-2'-Oxo-1',2',5,7- Tetrahydrospiro[cyclopenta[b]pyridine-6,3'- Pyrrolo[2,3-b]pyridine]-3-carboxylic Acid | 1375541-21-1 |
| Tert-butyl ((3S,5S,6R)-6-methyl-2-oxo-5-(2,3,6- Trifluorophenyl)piperidin-3-yl)carbamate | 1456803-43-2 | |
|
Avapritinib
|
6-Bromo-4-chloropyrrolo[2,1-f][1,2,4]triazine | 916420-30-9 |
| 6-Bromopyrrolo[2,1-f][1,2,4]triazin-4(1H)-one | 888721-83-3 | |
| Tert-butyl 4-[5-(4-fluorobenzoyl)pyrimidin-2- Yl]piperazine-1-carboxylate | 1703794-73-3 | |
| (4-fluorophenyl)[2-(1-piperazinyl)-5-pyrimidinyl]- Methanone Hydrochloride | 1703795-52-1 | |
| 6-(1-Methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4] Triazin- 4(1H)-one | 1703794-32-4 | |
| 4-Chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1- F][1,2,4]triazine | 1703794-33-5 | |
|
Belzutifan
|
3-Fluoro-5-((7-(methylsulfonyl)-1-oxo-2,3-dihydro- 1H- Inden-4-yl)oxy)benzonitrile | 1672665-55-2 |
|
Bosutinib
|
N2 | 380844-49-5 |
| Fragment A | 98446-49-2 | |
|
Belumosudil
|
2-bromo-N-isopropylacetamide | 75726-96-4 |
| 1-Boc-5-aminoindazole | 129488-10-4 | |
| Phenol, 3-(4-chloro-2-quinazolinyl)-, 1-acetate | 911417-24-8 | |
| N-2 | 911417-26-0 | |
|
Cannabidiol
|
(1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol | 22972-51-6 |
| Methyl 2,4-dihydroxy-6-pentylbenzoate | 58016-28-7 | |
| Olivetol | 500-66-3 | |
|
Carfilzomib
|
N2 | 247068-82-2 |
| N1 | 247068-85-5 | |
|
Ceritinib
|
Fragment A | 1032903-50-6 |
| Fragment B | 761440-16-8 | |
|
Cenicriviroc
|
4-(2-Butoxyethoxy)phenylboronic Acid | 279262-28-1 |
| 4-[[(1-Propyl-1H-imidazol-5- Yl)methyl]thio]benzenamine | 597583-17-0 | |
| 8-Bromo-1,2,3,4-tetrahydro-1-(2-methyl Propyl)-1-benzazocine-5-carboxylic Acid | 597583-12-5 | |
| (S)-4-[[(1-Propylimidazol-5-yl)methyl]sulfinyl]aniline | 497223-38-8 | |
|
Cenobamate
|
(R)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethanol | 1259059-77-2 |
| 1-(2-chlorophenyl)-2-(1,2,3,4-tetrazol-2-yl)ethan-1-one | 1259059-71-6 | |
| Oxirane, (2-chlorophenyl)-, (2R)- | 62566-66-9 | |
|
Darolutamide
|
5-Acetyl-1H-Pyrazole-3-Carboxylic Acid | 1297537-45-1 |
| 4-bromo-2-chlorobenzonitrile | 903550-26-5 | |
| 1-tetrahydropyran-1H-pyrazolylboronic Ester | 154607-01-9 | |
| 2-Chloro-4-(1H-pyrazol-3-yl)benzonitrile | 1297537-37-1 | |
| (S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2- Chlorobenzonitrile | 1297537-41-7 | |
|
Dapagliflozin
|
Dapagliflozin Tetraacetate | 461432-25-7 |
|
Deucravacitinib
|
3-pyridazinecarboxylic Acid, 4,6-dichloro-, Lithium Salt,hydrate | 2245111-15-1 |
| 2-Methoxy-3-(1-methyl-1H-1,2,4-triazol-3- Yl)benzenamine | 1609394-10-6 | |
| Ethyl 1,6-dihydro-4-hydroxy-6-oxo-3- Pyridazinecarboxylate | 1352925-63-3 | |
|
Dunuglipron
|
Methyl (S)-2-(Chloromethyl)-1-(2-oxetanylmethyl) -1H- Benzo[d]imidazole-6-carboxylate | 2230200-76-5 |
| 3-fluoro-4-(((6-(piperidin-4-yl)pyridin-2-yl )oxy)methyl)benzonitrile Bis(4-methyl Benzenesulfonate) | 2230200-25-4 | |
|
Drospirenone
|
N2 | 82543-16-6 |
|
Eplerenone
|
Fragment A | 192569-17-8 |
| N2 | 95716-70-4 | |
|
Empagliflozin
|
Acetoxy Empagliflozin | 915095-99-7 |
| 5-Bromo-2-chlorobenzoic Acid | 21739-92-4 | |
|
Erythromycin Thiocyanate
|
NA | 7704-67-8 |
|
ECC5004
|
(S)-3-(1-cyanocyclopropyl)-7-(2,2-dimethyltetrahydro- 2H-pyran-4-yl)indolizine-2-carboxylic Acid | 2758661-32-2 |
| 5-bromo-4-fluoro-1-methyl-1H-indazole | 1784678-61-0 | |
| Tert-butyl (S)-3-amino-2-(3-cyclopropyl-4-fluorophenyl)- 4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine- 5-carboxylate | NA | |
| Tert-butyl (S)-2-(3-cyclopropyl-4-fluorophenyl)-4-methyl- 3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7- Tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate | NA | |
| (3-cyclopropyl-4-fluorophenyl)hydrazine | 2758662-19-8 | |
| Tert-butyl (2S)-3-cyano-2-methyl-4-oxopiperidine-1- Carboxylate | 2212021-56-0 | |
| 5-bromo-4-fluoro-1-methyl-1H-indazole | 1784678-61-0 | |
|
Eribulin
|
EA | 871360-09-7 |
| EB | 157322-47-9 | |
| EC | 1808153-90-3 | |
| EB+C | 253128-10-8 | |
|
Fesoterodine
|
N2 | 207679-81-0 |
|
Filgotinib
|
5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine | 1010120-55-4 |
| Cyclopropanecarboxylic Acid (5-bromo- [1,2,4]triazolo[1,5-a]pyridin-2-yl)amide | 1142943-96-1 | |
| 5-chloro-[1,2,4]triazolo[1,5-a]pyridin-2-amine | 175965-64-7 | |
| 2-(4-(Bromomethyl)phenyl)-4,4,5,5-tetramethyl- 1,3,2-dioxaborolane | 138500-85-3 | |
| Thiomorpholine 1,1-Dioxide Hydrochloride | 59801-62-6 | |
| 4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)- Benzyl]-thiomorpholine-1,1-dioxide | 1092563-25-1 | |
|
Finerenone
|
4-Amino-5-methyl-2(1H)-pyridinone | 95306-64-2 |
| 2-Methoxy-4-cyanobenzaldehyde | 21962-45-8 | |
| (Z)-2-cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate | 1050477-39-8 | |
|
Fezolinetant
|
(R)-3-methyl-2-ketopiperazine | 922178-61-8 |
| 3-Methyl-1,2,4-thiadiazole-5-carbohydrazide | 1375066-73-1 | |
|
Fulvestrant
|
N2 | 875573-69-6 |
|
Gemcitabine
|
T6 | 122111-01-7 |
| T8 | 122111-11-9 | |
|
Isavuconazonium Sulfate
|
2-(methylamino)pyridin-3-yl)methyl 2-((tertbutoxycarbonyl)(methyl)amino)acetate | 1180002-01-0 |
| (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-Methyl- 4-(1H-1,2,4-triazol-1-yl)thiobutyraMide | 368421-58-3 | |
| (2-(((1-Chloroethoxy)carbonyl)(methyl)amino)pyridin-3- Yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate | 338990-31-1 | |
|
Ibrutinib
|
Fragment A | 330786-24-8 |
| Fragment A | 143900-44-1 | |
|
Iptacopan
|
Benzyl (2S,4S)-4-ethoxy-2-(4-(methoxycarbonyl) Phenyl)piperidine-1-carboxylate | 1644667-60-6 |
| 4-((2S,4S)-1-((benzyloxy)carbonyl)-4- Ethoxypiperidin-2-yl)benzoic Acid | 1644667-59-3 | |
| Benzyl (2S,4S)-2-(4-cyanophenyl)-4-ethoxypiperidine-1-carboxylate | 1644667-58-2 | |
| Benzyl (2S,4S)-2-(4-cyanophenyl)-4-hydroxypiperidine-1-carboxylate | 1644667-60-6 | |
| Tert-Butyl 4-formyl-5-methoxy-7-methyl- 1H-indole-1-carboxylate | 1481631-51-9 | |
| Methyl 4-[(2S,4S)-4-ethoxy-2-piperidinyl]benzoate | 1644667-61-7 | |
|
Lorlatinib
|
Fragment A | 1454847-96-1 |
| Fragment B | 1643141-20-1 | |
|
Lenvatinib
|
Fragment A | 417721-36-9 |
| Fragment B | 417717-20-5 | |
|
Lumateperone
|
(4aS,9bR)-6-bromo-1H,2H,3H,4H,4aH,5H, 9bH-pyrido[4,3-b]indole | 1059630-07-7 |
| 6-bromo-2,3,4,5-tetrahydro-1H-pyrido[4,3- B]indolehydrochloride | 1059630-11-3 | |
| Ethyl (4aS,9bR)-6-bromo-5-(2-(methylamino)-2- Oxoethyl)-1,3,4,4a,5,9b-hexahydro-2H-pyrido[4,3- B]indole-2-carboxylate | 2098497-32-4 | |
|
Lenacapavir
|
4-Chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- Yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine | 2189684-53-3 |
| 2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5- Tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol- 1-yl)acetic Acid | 1620056-83-8 | |
| Carbamic Acid,N-[(1S)-1-[3-bromo-6-[3-methyl-3- (methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5- Difluorophenyl)ethyl]-,1,1-dimethylethyl Ester | 2189684-54-4 | |
| Tert-Butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2-(3,5- Difluorophenyl)ethyl)carbamate | 1620056-47-4 | |
|
Lurbinectedin
|
Corey 16 | 265134-87-0 |
| Corey 21 | 182201-62-3 | |
|
Lapatinib
|
Fragment A | 104458-24-4 |
| Fragment B | 27329-70-0 | |
| Fragment C | 231278-20-9 | |
|
Mavacamten
|
Isopropylurea | 691-60-1 |
| 1-Isopropylpyrimidine-2,4,6(1H,3H,5H)-trione | 69998-14-7 | |
| 6-Chloro-3-isopropylpyrimidine-2,4(1H,3H)-dione | 887581-47-7 | |
|
Mirogabalin
|
3-Ethyl Bicyclo [3.2.0]hept-3-en-6-one | 1235479-59-0 |
| (1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one | 1235479-61-4 | |
|
Maribavir
|
1,2,3,5-Tetra-O-Acetyl-Beta-L-Ribofuranose | 144490-03-9 |
| 2-Bromo-5,6-Dichlorobenzimidazole | 142356-40-9 | |
|
Milvexian
|
[(S)-tert-butyl 1-(4-chloropyridin-2-yl)but-3- Enylcarbamate] | 1329171-69-8 |
| 1-(difluoromethyl)-4-nitro-1H-pyrazole | 956477-64-8 | |
| (R)-2-methylbut-3-enoic Acid | 20626-49-7 | |
| 6-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1- Yl)phenyl]pyrimidin-4-ol | 1802430-55-2 | |
|
Orforglipron
|
5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-1-((1S,2S)- 2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3- Yl)cyclopropyl)-1H-indole-2-carboxylic Acid | 2212021-83-3 |
| Ethyl (S)-5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1Hindole-2-carboxylate | 2212021-77-5 | |
| Ethyl (R)-5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1Hindole-2-carboxylate | 2758661-69-5 | |
| Tert-butyl (S)-3-amino-2-(4-fluoro-3,5-dimethylphenyl)- 4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine- 5-carboxylate | 2212021-59-3 | |
| Tert-butyl (S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl- 3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7- Tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate | 2212021-61-7 | |
| Di-tert-butyl 1-(4-fluoro-3,5-dimethylphenyl)hydrazine- 1,2-dicarboxylate | 2212021-55-9 | |
| Tert-butyl (2S)-3-cyano-2-methyl-4-oxopiperidine-1- Carboxylate | 2212021-56-0 | |
|
Osimertinib
|
4-fluoro-2-Methoxy-5-nitroaniline | 1075705-01-9 |
| 3-(2-chloropyriMidin-4-yl)-1-Methylindole | 1032452-86-0 | |
| N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4- (4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2- Nitrobenzene-1,4-diamine | 1421372-67-9 | |
| N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1Hindol-3-yl)pyrimidin-2-amine | 1421372-94-2 | |
| N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4- (4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4- Triamine | 1421372-66-8 | |
|
Neratinib
|
Fragment A | 848133-76-6 |
| Fragment B | 524955-09-7 | |
|
Niraparib
|
Fragment A | 1171197-20-8 |
| Fragment B | 677304-69-7 | |
|
Nintedanib Ethanesulfonate Salt
|
Fragment A | 14192-26-8 |
| Fragment B | 1168150-46-6 | |
| Fragment C | 1139453-98-7 | |
|
Olaparib
|
N2 | 763114-25-6 |
|
Pazopanib
|
N2 | 635702-60-2 |
|
Pexidartinib
|
5-Chloro-1H-pyrrolo[2,3-b]pyridine | 866546-07-8 |
| 6-(Trifluoromethyl)-3-pyridinecarboxaldehyde | 386704-12-7 | |
| 5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3- Yl)methyl]-2-pyridinamine | 2040295-04-1 | |
|
Palbociclib
|
Tert-butyl 4-(6-aminopyridin-3- Yl)piperazine-1-carboxylate | 571188-59-5 |
| 6-bromo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3- D]pyrimidin-7(8H)-one | 1016636-76-2 | |
|
Pirtobrutinib
|
(1S)-2,2,2-trifluoro-1-methylethyl]hydrazine Hydrochloride | 2764851-03-6 |
| N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl] Methyl]-5-fluoro-2-methoxy-benzamide | 2764851-04-7 | |
|
Rimegepant
|
7,8-Dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione | 39713-40-1 |
| (6S,9R)-6-(2,3-Difluorophenyl)-9-((triisopropylsilyl)oxy)- 6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-one | 1190363-46-2 | |
| (5S,6S,9R)-6-(2,3-difluorophenyl)-9- ((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5Hcyclohepta[b]pyridin-5-aminedihydrochloride | 1373116-04-1 | |
| 1,3-Dihydro-1-[1-(1H-imidazol-1-ylcarbonyl)-4- Piperidinyl]-2H-imidazo[4,5-b]pyridin-2-one | 1373116-06-3 | |
|
Ribociclib
|
2-Chloro-7-cyclopentyl-n,n-dimethyl-7h-pyrrolo[2,3d]pyrimidine-6-carboxamide | 1211443-61-6 |
| 2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]- Pyrimidine-6-carboxylic Acid | 1211443-58-1 | |
| 1-boc-4-(6-aminopyridin-3-yl)piperazine | 571188-59-5 | |
|
Rucaparib
|
8-Fluoro-1,3,4,5-tetrahydro-6H-pyrrolo[4,3,2- Ef][2]benzazepin-6-one | 1408282-26-7 |
| Fragment A | 283173-72-8 | |
| Fragment B | 1082040-43-4 | |
|
Roxadustat
|
5-phenoxyisobenzofuran-1(3H)-one | 57830-14-5 |
| Methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate | 1455091-10-7 | |
| Methyl 1,4-dihydroxy-7-phenoxyisoquinoline-3- Carboxylate | 1421312-32-4 | |
| Ethyl 1,4-dihydroxy-7-phenoxyisoquinoline-3-carboxylate | 2244489-54-9 | |
| 4-Hydroxy-1-methyl-7-phenoxy-3- Isoquinolinecarboxylic Acid Methyl Ester | 1421312-34-6 | |
|
Resmetirom
|
3,6-Dichloro-4-isopropylpyridazine | 107228-51-3 |
| 3,5-dichloro-4-((6-chloro-5-isopropylpyridazin- 3-yl)oxy)aniline | 920509-27-9 | |
| 6-(4-Amino-2,6-Dichlorophenoxy)-4- Isopropylpyridazin-3(2H)-One | 920509-28-0 | |
| N-Cyanoacetylurethane | 6629-04-5 | |
|
Ritlecitinib
|
(2S,5R)-Benzyl 5-amino-2-methylpiperidine-1- Carboxylate Hydrochloride | 1207853-23-3 |
| 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine | 90213-66-4 | |
| Ritecitinib Intermediate | 2042650-70-2 | |
| 1-[(2S,5R)-2-Methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4- Ylamino)-1-piperidinyl]-2-propen-1-one Malonate | 1792180-81-4 | |
|
Sacubitril
|
(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tertbutoxycarbonyl)amino)-2-methylpentanoic Acid | 1012341-50-2 |
| (2R,4S)-4-Amino-5-(biphenyl-4-yl)-2-methylpentanoic Acid Ethyl Ester Hydrochloride | 149690-12-0 | |
|
Semaglutide Side Chain
|
Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH | 1662688-20-1 |
|
Selumetinib
|
O-(2-tert-butoxyethyl)hydroxylaMine | 1023742-13-3 |
| Methyl 6-((4-bromo-2-chlorophenyl)amino)- 7-fluoro-1H-benzo[d]imidazole-5-carboxylate | 606143-46-8 | |
| O-(2-(vinyloxy)ethyl)hydroxylamine | 391212-29-6 | |
|
Sotorasib
|
7-Chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin- 3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione | 2252403-82-8 |
| (S)-4-N-Boc-2-methylpiperazine | 147081-29-6 | |
| 2-isopropyl-4-methylpyridin-3-amine | 1698293-93-4 | |
| 2-Fluoro-6-methoxyphenylboronic Acid | 78495-63-3 | |
|
Sparsentan
|
3-Amino-4,5-dimethylisoxazole | 13999-39-8 |
| (2-(N-(4,5-dimethylisoxazol-3-yl)-N- (methoxymethyl)sulfamoyl)phenyl)boronic Acid | 415697-58-4 | |
| 2-bromo-N-(4,5-dimethylisoxazol-3- Yl)benzenesulfonamide | 195447-72-4 | |
| 2-bromo-N-(4,5-dimethylisoxazol-3-yl)-N- (methoxymethyl)benzenesulfonamide | 415697-57-3 | |
|
Sitagliptin
|
2,4,5-Trifluorophenylacetic Acid | 209995-38-0 |
| Boc-(R)-3-Amino-4-(2,4,5-Trifluorophenyl)-Butyric Acid | 486460-00-8 | |
| 3-(Trifluoromethyl)-5,6,7,8-tetrahydro- [1,2,4]triazolo[4,3-a]pyrazine Hydrochloride | 762240-92-6 | |
| Sitagliptin Base | 486460-32-6 | |
|
Talazoparib
|
Fragment A | 1620153-74-3 |
| Fragment B | 1322616-36-3 | |
|
Telotristat Etiprate LX 1606
|
Fragment A | 1033805-26-3 |
| N2 | 1033805-28-5 | |
|
Tegoprazan
|
R-5,7-Difluorochroman-4-ol | 1270294-05-7 |
| 1-benzyl-4-hydroxy-2-methyl-1Hbenzimidazole-6-carboxylic Acid | 1640981-19-6 | |
| 7-hydroxy-N,N,2-triMethyl-3-tosyl-3Hbenzo[d]iMidazole-5-carboxaMide | 942195-86-0 | |
|
Tofacitinib Citrate
|
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine | 3680-69-1 |
| BAP-L-Tartrate | 477600-71-8 | |
|
Trilaciclib
|
5-(4-Methyl-1-piperazinyl)-2-pyridinamine | 571189-49-6 |
| Ethyl 2-(methylthio)-4-(3-oxo-1,4-diazaspiro- [5.5]undecan-1-yl)pyrimidine-5-carboxylate | 2170746-95-7 | |
| Spiro[cyclohexane-1,9'(6'H)-pyrazino- [1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)- Carboxylic Acid, 2'-(methylthio)-6'-oxo-, 1,1- Dimethylethyl Ester | 2170746-99-1 | |
|
Tirzepatide
|
Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH | 2460751-66-8 |
| 20-(tert-Butoxy)-20-oxoicosanoic Acid | 683239-16-9 | |
|
Ubrogepant
|
1-(1,1-Dimethylethyl)-1,3-dihydro-2Hpyrrolo[2,3-b]pyridin-2-one | 1455358-06-1 |
| Ubrogepant Intermediate | 1375541-21-1 | |
| (3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2- Trifluoroethyl)piperidine-3-aminium 4-nitrobenzoate | 1456803-37-4 | |
|
Upadacitinib
|
(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1- Pyrrolidinecarboxylic Acid Phenylmethyl Ester | 1428243-26-8 |
| 5-Bromo-4,7-diazaindole | 875781-43-4 | |
|
Vibegron
|
(1R,2R)-2-amino-6-(4-nitrophenyl)-1- Phenylhex-5-yn-1-olhydrochloride | 1628836-08-7 |
| (6S)-4,6,7,8-tetrahydro-4-oxo-Pyrrolo[1,2- A]pyriMidine-6-carboxylic Acid | 1190392-22-3 | |
|
Venetoclax (ABT-199)
|
Fragment A | 1228780-72-0 |
| Fragment B | 1228779-96-1 | |
|
Vonoprazan
|
5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde | 881674-56-2 |
| Pyridine-3-sulfonyl Chloride | 16133-25-8 | |
|
Voxelotor
|
(2-Chloro-3-pyridinyl)methanol | 42330-59-6 |
| 3-Pyridinemethanol, 2-[1-(1-methylethyl)-1H-pyrazol- 5-yl]-, Hydrochloride (1:1) | 2245886-82-0 | |
| 2-hydroxy-6-(methoxymethoxy)benzaldehyde | 84290-49-3 | |
|
Zavegepant
|
1-(1-Methyl-4-piperidinyl)piperazine | 23995-88-2 |
| Methyl (2R)-2-amino-3-(7-methyl-1H-indazol- 5-yl)propanoate Dihydrochloride | 1414976-14-9 | |
| 3-(Piperidin-4-yl)quinolin-2(1H)-one Hydrochloride | 855778-84-6 | |
| Methyl 2-(phenylmethoxycarbonylamino)prop-2-enoate | 21149-17-7 | |
| Methyl (R)-2-(benzyloxycarbonylamino)-3-(7- Methyl-1H-indazol-5-yl)-propanoate | 85578-40-4 |